PolarisQB and Fujitsu Launch Drug Discovery Platform
by Rich Brueckner from High-Performance Computing News Analysis | insideHPC on (#5159Q)
Polarisqb has partnered with Fujitsu to create a ground-breaking drug discovery platform combining quantum-inspired technology, machine learning, hybrid quantum mechanics and molecular mechanics simulations (QM/MM). This new platform enables significantly faster, more cost-effective discovery of novel lead molecules to develop new drugs. Polarisqb and Fujitsu have begun a drug discovery project targeting Dengue Fever which has no approved treatments.
The post PolarisQB and Fujitsu Launch Drug Discovery Platform appeared first on insideHPC.